0 0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 5,456 xbrli:pure xbrli:shares iso4217:GBP 04264397 2024-01-01 2024-12-31 04264397 2024-12-31 04264397 2023-12-31 04264397 2023-01-01 2023-12-31 04264397 2023-12-31 04264397 2022-12-31 04264397 bus:RegisteredOffice 2024-01-01 2024-12-31 04264397 bus:Director1 2024-01-01 2024-12-31 04264397 core:WithinOneYear 2024-12-31 04264397 core:WithinOneYear 2023-12-31 04264397 core:AfterOneYear 2024-12-31 04264397 core:AfterOneYear 2023-12-31 04264397 core:RetainedEarningsAccumulatedLosses 2023-12-31 04264397 core:RetainedEarningsAccumulatedLosses 2022-12-31 04264397 core:RetainedEarningsAccumulatedLosses 2024-12-31 04264397 core:RetainedEarningsAccumulatedLosses 2023-12-31 04264397 bus:SmallEntities 2024-01-01 2024-12-31 04264397 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 04264397 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 04264397 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04264397 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 04264397
Bellerophon Investment Management Limited
Unaudited Financial Statements
31 December 2024
Bellerophon Investment Management Limited
Financial Statements
Year ended 31 December 2024
Contents
Page
Director's report
1
Statement of income and retained earnings
2
Statement of financial position
3
Notes to the financial statements
4
Bellerophon Investment Management Limited
Director's Report
Year ended 31 December 2024
The director presents his report and the unaudited financial statements of the company for the year ended 31 December 2024 .
Director
The director who served the company during the year was as follows:
Mr J Argyriou
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 22 September 2025 and signed on behalf of the board by:
Mr J Argyriou
Director
Registered office:
490 Sidcup Road
Greater London
SE9 4HA
Bellerophon Investment Management Limited
Statement of Income and Retained Earnings
Year ended 31 December 2024
2024
2023
Note
£
£
Administrative expenses
–
5,456
----
-------
Operating loss
–
( 5,456)
----
-------
Loss before taxation
–
( 5,456)
Tax on loss
–
–
----
-------
Loss for the financial year and total comprehensive income
–
( 5,456)
----
-------
Retained losses at the start of the year
( 111,359)
( 105,903)
---------
---------
Retained losses at the end of the year
( 111,359)
( 111,359)
---------
---------
All the activities of the company are from continuing operations.
Bellerophon Investment Management Limited
Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
Current assets
Debtors
4
4,883
4,883
Cash at bank and in hand
2,106
143
-------
-------
6,989
5,026
Creditors: amounts falling due within one year
5
( 7,309)
( 7,310)
--------
--------
Net current assets
14,298
12,336
--------
--------
Total assets less current liabilities
14,298
12,336
Creditors: amounts falling due after more than one year
6
125,657
123,695
---------
---------
Net liabilities
( 111,359)
( 111,359)
---------
---------
Capital and reserves
Profit and loss account
( 111,359)
( 111,359)
---------
---------
Shareholders deficit
( 111,359)
( 111,359)
---------
---------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 22 September 2025 , and are signed on behalf of the board by:
Mr J Argyriou
Director
Company registration number: 04264397
Bellerophon Investment Management Limited
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 490 Sidcup Road, SE9 4HA, Greater London.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors
2024
2023
£
£
Other debtors
4,883
4,883
-------
-------
5. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
( 7,309)
( 7,310)
-------
-------
6. Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
125,657
123,695
---------
---------